Skip to main content

Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Mecanismos subyacentes del daño axonal y discapacidad en enfermedad asociada a anticuerpos anti-MOG: Estudio MOGAXON

IP: Alvaro Cobo Calvo
Collaborators: Cristina Auger Acosta, Elisa Marín Ordovás, Mireia Castillo Juarez, Luca Bollo
Funding agency: Instituto de Salud Carlos III
Funding: 201875
Reference: PI24/00859
Duration: 01/01/2025 - 31/12/2027

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Patricia Picallo Ramos

Patricia Picallo Ramos

Research technician
Nephrology and kidney transplantation
Read more
Julian Piñeiro Fernandez

Julian Piñeiro Fernandez

Research technician
Translational Molecular Pathology
Read more
Maria Morillo Soriano

Maria Morillo Soriano

Research assistant
Growth and Development
Read more
Pere Nubiola Rivera

Pere Nubiola Rivera

Research assistant
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.